Correlation Between Ardelyx and Lexicon Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Ardelyx and Lexicon Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ardelyx and Lexicon Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ardelyx and Lexicon Pharmaceuticals, you can compare the effects of market volatilities on Ardelyx and Lexicon Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ardelyx with a short position of Lexicon Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ardelyx and Lexicon Pharmaceuticals.
Diversification Opportunities for Ardelyx and Lexicon Pharmaceuticals
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Ardelyx and Lexicon is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Ardelyx and Lexicon Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lexicon Pharmaceuticals and Ardelyx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ardelyx are associated (or correlated) with Lexicon Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lexicon Pharmaceuticals has no effect on the direction of Ardelyx i.e., Ardelyx and Lexicon Pharmaceuticals go up and down completely randomly.
Pair Corralation between Ardelyx and Lexicon Pharmaceuticals
Given the investment horizon of 90 days Ardelyx is expected to generate 0.66 times more return on investment than Lexicon Pharmaceuticals. However, Ardelyx is 1.51 times less risky than Lexicon Pharmaceuticals. It trades about -0.05 of its potential returns per unit of risk. Lexicon Pharmaceuticals is currently generating about -0.34 per unit of risk. If you would invest 590.00 in Ardelyx on August 28, 2024 and sell it today you would lose (65.00) from holding Ardelyx or give up 11.02% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ardelyx vs. Lexicon Pharmaceuticals
Performance |
| Timeline |
| Ardelyx |
| Lexicon Pharmaceuticals |
Ardelyx and Lexicon Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ardelyx and Lexicon Pharmaceuticals
The main advantage of trading using opposite Ardelyx and Lexicon Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ardelyx position performs unexpectedly, Lexicon Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lexicon Pharmaceuticals will offset losses from the drop in Lexicon Pharmaceuticals' long position.| Ardelyx vs. Eliem Therapeutics | Ardelyx vs. HCW Biologics | Ardelyx vs. Scpharmaceuticals | Ardelyx vs. Milestone Pharmaceuticals |
| Lexicon Pharmaceuticals vs. BioLineRx | Lexicon Pharmaceuticals vs. Ardelyx | Lexicon Pharmaceuticals vs. Seres Therapeutics | Lexicon Pharmaceuticals vs. Immunitybio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |